Patients with Atopic Dermatitis Reported Rapid and Optimal Real-World Effectiveness with Upadacitinib: SCALE-UP Study Results by Prior Treatment
Jonathan I. Silverberg(George Washington University), Christopher G. Bunick(Yale University), Bang Truong(Auburn University), Zelma C. Chiesa Fuxench(University of Pennsylvania), Ayman Grada(University Hospitals of Cleveland), Arielle G. Bensimon(Analysis Group (United States)), Chao Li(Eli Lilly (United States)), Diego Ruiz Dasilva(Eastern Virginia Medical School), Jiaxuan Liu(Hefei National Center for Physical Sciences at Nanoscale), Brian Calimlim(AbbVie (United States))
Cited by 0
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Genomic landscape of cutaneous T cell lymphoma
|Nature Genetics|2015|418
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|389
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377